177 related articles for article (PubMed ID: 22507746)
1. Weak estrogenic transcriptional activities of Bisphenol A and Bisphenol S.
Grignard E; Lapenna S; Bremer S
Toxicol In Vitro; 2012 Aug; 26(5):727-31. PubMed ID: 22507746
[TBL] [Abstract][Full Text] [Related]
2. Alternative methods in vitro for screening of endocrine disruptors.
Dvořáková M; Kejlová K; Bendová H; Rucki M; Kohout P; Vavrouš A; Jírová D
Neuro Endocrinol Lett; 2016 Dec; 37(Suppl1):123-131. PubMed ID: 28263540
[TBL] [Abstract][Full Text] [Related]
3. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency.
Yoshihara S; Mizutare T; Makishima M; Suzuki N; Fujimoto N; Igarashi K; Ohta S
Toxicol Sci; 2004 Mar; 78(1):50-9. PubMed ID: 14691209
[TBL] [Abstract][Full Text] [Related]
4. Ipso substitution of bisphenol A catalyzed by microsomal cytochrome P450 and enhancement of estrogenic activity.
Nakamura S; Tezuka Y; Ushiyama A; Kawashima C; Kitagawara Y; Takahashi K; Ohta S; Mashino T
Toxicol Lett; 2011 May; 203(1):92-5. PubMed ID: 21402134
[TBL] [Abstract][Full Text] [Related]
5. Estrogenic potency of bisphenol S, polyethersulfone and their metabolites generated by the rat liver S9 fractions on a MVLN cell using a luciferase reporter gene assay.
Kang JS; Choi JS; Kim WK; Lee YJ; Park JW
Reprod Biol Endocrinol; 2014 Nov; 12():102. PubMed ID: 25371027
[TBL] [Abstract][Full Text] [Related]
6. Receptor binding characteristics of the endocrine disruptor bisphenol A for the human nuclear estrogen-related receptor gamma. Chief and corroborative hydrogen bonds of the bisphenol A phenol-hydroxyl group with Arg316 and Glu275 residues.
Liu X; Matsushima A; Okada H; Tokunaga T; Isozaki K; Shimohigashi Y
FEBS J; 2007 Dec; 274(24):6340-51. PubMed ID: 18005256
[TBL] [Abstract][Full Text] [Related]
7. Changes in the mutagenic and estrogenic activities of bisphenol A upon treatment with nitrite.
Masuda S; Terashima Y; Sano A; Kuruto R; Sugiyama Y; Shimoi K; Tanji K; Yoshioka H; Terao Y; Kinae N
Mutat Res; 2005 Aug; 585(1-2):137-46. PubMed ID: 15936980
[TBL] [Abstract][Full Text] [Related]
8. Novel pathway of metabolic activation of bisphenol A-related compounds for estrogenic activity.
Okuda K; Fukuuchi T; Takiguchi M; Yoshihara S
Drug Metab Dispos; 2011 Sep; 39(9):1696-703. PubMed ID: 21636669
[TBL] [Abstract][Full Text] [Related]
9. Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.
Letcher RJ; Sanderson JT; Bokkers A; Giesy JP; van den Berg M
Toxicol Appl Pharmacol; 2005 Dec; 209(2):95-104. PubMed ID: 15907334
[TBL] [Abstract][Full Text] [Related]
10. Computer-aided identification of novel protein targets of bisphenol A.
Montes-Grajales D; Olivero-Verbel J
Toxicol Lett; 2013 Oct; 222(3):312-20. PubMed ID: 23973438
[TBL] [Abstract][Full Text] [Related]
11. A simple and extremely sensitive system for detecting estrogenic activity using transgenic Arabidopsis thaliana.
Tojo T; Tsuda K; Wada TS; Yamazaki K
Ecotoxicol Environ Saf; 2006 Jun; 64(2):106-14. PubMed ID: 16406577
[TBL] [Abstract][Full Text] [Related]
12. Bisphenol A impairs estradiol-induced protective effects against DLD-1 colon cancer cell growth.
Bolli A; Bulzomi P; Galluzzo P; Acconcia F; Marino M
IUBMB Life; 2010 Sep; 62(9):684-7. PubMed ID: 20836126
[TBL] [Abstract][Full Text] [Related]
13. Bisphenol A induces corticotropin-releasing hormone expression in the placental cells JEG-3.
Huang H; Tan W; Wang CC; Leung LK
Reprod Toxicol; 2012 Nov; 34(3):317-22. PubMed ID: 22564983
[TBL] [Abstract][Full Text] [Related]
14. Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice.
Gioiosa L; Fissore E; Ghirardelli G; Parmigiani S; Palanza P
Horm Behav; 2007 Sep; 52(3):307-16. PubMed ID: 17568585
[TBL] [Abstract][Full Text] [Related]
15. Additive estrogenic activities of the binary mixtures of four estrogenic chemicals in recombinant yeast expressing human estrogen receptor.
Kang KS; Cho SD; Lee YS
J Vet Sci; 2002 Mar; 3(1):1-5. PubMed ID: 14614265
[TBL] [Abstract][Full Text] [Related]
16. Transient inhibition of synergistically insulin-like growth factor-1- and bisphenol A-induced poliferation of estrogen receptor alpha (ERalpha)-positive human breast cancer MCF-7 cells by melatonin.
Ishido M
Environ Sci; 2004; 11(3):163-70. PubMed ID: 15750583
[TBL] [Abstract][Full Text] [Related]
17. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma.
Okada H; Tokunaga T; Liu X; Takayanagi S; Matsushima A; Shimohigashi Y
Environ Health Perspect; 2008 Jan; 116(1):32-8. PubMed ID: 18197296
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors.
Bursztyka J; Perdu E; Pettersson K; Pongratz I; Fernández-Cabrera M; Olea N; Debrauwer L; Zalko D; Cravedi JP
Toxicol In Vitro; 2008 Sep; 22(6):1595-604. PubMed ID: 18640261
[TBL] [Abstract][Full Text] [Related]
19. Bisphenol compounds regulate decidualized stromal cells in modulating trophoblastic spheroid outgrowth and invasion in vitro†.
Fan H; Jiang L; Lee YL; Wong CKC; Ng EHY; Yeung WSB; Lee KF
Biol Reprod; 2020 Mar; 102(3):693-704. PubMed ID: 31742322
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.
Akahori Y; Nakai M; Yamasaki K; Takatsuki M; Shimohigashi Y; Ohtaki M
Toxicol In Vitro; 2008 Feb; 22(1):225-31. PubMed ID: 17904329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
